A detailed history of Atria Wealth Solutions, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 16,775 shares of SAVA stock, worth $451,415. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,775
Previous 13,779 21.74%
Holding current value
$451,415
Previous $170,000 190.0%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$9.57 - $35.08 $28,671 - $105,099
2,996 Added 21.74%
16,775 $493,000
Q2 2024

Jul 22, 2024

BUY
$12.35 - $26.11 $170,170 - $359,769
13,779 New
13,779 $170,000
Q4 2023

Feb 02, 2024

BUY
$12.64 - $30.11 $115,024 - $274,001
9,100 New
9,100 $204,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.08B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.